Acute migraine treatment: patterns of use and satisfaction in a clinical population

Headache
Shahram N MalikStephen D Silberstein

Abstract

The sequence and timing of taking migraine medications, whether prescription or over-the-counter, and the patient's response to their treatment, is unknown. To describe the use of, response to, and satisfaction with acute medications for 1 migraine attack. We performed a clinic-based survey of 127 patients at Jefferson Headache Center, Philadelphia. Adult patients who met the International Headache Society criteria for migraine with or without aura were included in the study. Patients were asked to complete a questionnaire. Of 109 participants who met the inclusion criteria, most waited 1 hour or more after the onset of symptoms to take medication. Triptans were most commonly used as first, second, and third medications. Triptan use was associated with higher 2-hour pain-free response rates compared with other agents, whether the triptan was used as the first, second, or third medication. Patients who were treated with medications other than triptans were more likely to have pain at 2 hours (P = .36). NSAIDs had relatively low pain-free and headache relief response rates at 2 hours. Sixty-two participants (56.9%) had to treat a second time and 31 (28.4%) had to treat a third time. Some participants (17.6%) had headache recurren...Continue Reading

References

Feb 1, 1979·Pain·Myra HunterStanley Rachman
Jan 1, 1992·JAMA : the Journal of the American Medical Association·W F StewartM L Reed
Jul 1, 1982·Pain·S J Linton, L Melin
Feb 1, 1997·Neurologic Clinics·R B Lipton, W F Stewart
Apr 18, 1998·Lancet·M D Ferrari
Aug 6, 1994·PharmacoEconomics·R B LiptonM Von Korff
Dec 8, 1996·PharmacoEconomics·G D Solomon, K L Price
Feb 22, 2000·Clinical Cornerstone·R K Cady
Nov 15, 2000·Cephalalgia : an International Journal of Headache·G M DaviesR Lipton
Feb 13, 2001·Cephalalgia : an International Journal of Headache·P Tfelt-HansenUNKNOWN International Headache Society Clinical Trials Subcommittee
Dec 12, 2001·Cephalalgia : an International Journal of Headache·C Dahlöf
Apr 23, 2002·Headache·Richard B LiptonJeffrey M Dayno
Apr 23, 2002·Headache·Julio Pascual
Apr 12, 2003·Pharmacotherapy·Richard G WenzelMichelle L Krause
Nov 25, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Catherine AcquadroUNKNOWN PRO Harmonization Group
Apr 21, 2004·Cephalalgia : an International Journal of Headache·R B LiptonP J Goadsby
Apr 21, 2004·Cephalalgia : an International Journal of Headache·E Leinisch-DahlkeA May
May 29, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard Shikiar, Anne M Rentz
Feb 12, 2005·Headache·Luis E MorilloUNKNOWN Latin American Migraine Study Group

❮ Previous
Next ❯

Citations

Nov 15, 2008·The Journal of Headache and Pain·Bozena J KatićX Henry Hu
Sep 6, 2008·Cephalalgia : an International Journal of Headache·M Lantéri-Minet
May 15, 2009·Cephalalgia : an International Journal of Headache·S CevoliP Cortelli
Feb 19, 2009·Headache·Anna FerrariAlfio Bertolini
Feb 26, 2013·Headache·Kathleen R Merikangas
Oct 13, 2009·Headache·Bozena J KatićMarcelo E Bigal
Sep 26, 2015·Journal of Behavioral Medicine·Elizabeth K SengKenneth A Holroyd
Aug 19, 2014·TheScientificWorldJournal·Dorota TalarskaKarolina Hudaś
Apr 12, 2016·Expert Review of Neurotherapeutics·Steven P Cohen, Hira Chaudhry
Apr 29, 2015·The Journal of Headache and Pain·Stefan EversLorenzo Pinessi
Feb 22, 2012·Cephalalgia : an International Journal of Headache·Kerstin Hedborg, Carin Muhr
Jul 22, 2010·Cephalalgia : an International Journal of Headache·Anna FerrariEmilio Sternieri
Oct 13, 2010·Cephalalgia : an International Journal of Headache·Bozena J KatićX Henry Hu
Feb 28, 2008·The Annals of Pharmacotherapy·Lawrence A Frazee, Kimberly C Foraker
Jun 9, 2018·Cephalalgia : an International Journal of Headache·David DodickMessoud Ashina
Jan 20, 2018·CNS Spectrums·Stephen D Silberstein
Mar 15, 2006·Expert Review of Neurotherapeutics·Marcelo E Bigal, Richard B Lipton
Nov 8, 2018·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Jin-Eon HanIl-Sung Jang
Jun 24, 2021·Headache·Jessica AilaniUNKNOWN Board of Directors of the American Headache Society
Jan 29, 2021·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Christian PristipinoDariusz Dudek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Medical Bulletin
Naomi Rubin, Kevan Wylie
American Journal of Obstetrics and Gynecology
D Ashley HillGeorgine M Lamvu
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Marie H HaniganPatrick J Medina
JAMA : the Journal of the American Medical Association
David W KaufmanAllen A Mitchell
© 2022 Meta ULC. All rights reserved